[1] SUN H, GONG TT, JIANG YT, et al.Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990-2017: results from a global burden of disease study, 2017[J]. Aging(Albany NY), 2019, 11(23): 10952-10991. [2] BUTNEV VY, MAY JV, SHUAI B, et al.Production, purification, and characterization of recombinant hFSH glycoforms for functional studies[J]. Mol Cell Endocrinol, 2015, 405: 42-51. [3] MAO YH, WANG BG, XUE CX, et al.Bioethicity of recombinant human[J]. Chinese Journal Clinical Pharmacology(中国临床药理学杂志), 2022, 38(13): 1526-1530. [4] KWON O, JOUNG J, PARK Y, et al.Considerations of critical quality attributes in the analytical comparability assessment of biosimilar products[J]. Biologicals, 2017, 48: 101-108. [5] DEMAIN AL, VAISHNAV P.Production of recombinant proteins by microbes and higher organisms[J]. Biotechnology Advances, 2009, 27(3): 297-306. [6] LYU SJ, LIU ZL, WANG YY, et al.Determination of sialic acid in long-acting human erythropoiesis stimulating protein by ultra-performance liquid chromatography-fluorescence detection[J]. Food and Drug(食品与药品), 2022, 24(5): 416-419. [7] DHAR C, SASMAL A, VARKI A.From“serum sickness”to“xenosialitis”: past, present, and future significance of the non-human sialic acid Neu5Gc[J]. Frontiers in Immunology, 2019, 10: 807. [8] CHENG B, YANG HX, LIANG CG, et al.RP-HPLC determination of sialic acid in recombinant human follicle stimulating hormone[J]. Chin J Pharm Anal, 2007, 27(9): 1416-1419. [9] LI PP, YAN ZY, CHEN Y, et al.Determination of sialic acid in fish by ultra high performance liquid chromatography with DMBA derivatization[J]. Journal of Instrumental Analysis, 2022, 41(11): 1684-1689. [10] YEHUDA S, KARAVANI VP.Glycosylated biotherapeutics: immunological effects of N-glycolylneuraminic acid[J]. Frontiers in Immunology, 2020, 11(21): 1-9. [11] DING FD, LIN YF, LIU GZ, et al.Immune disguise: the mechanisms of Neu5Gc inducing autoimmune and transplant rejection[J]. Genes & Immunity, 2022, 23: 175-182. [12] XU X, NAGARAJAN H, LEWIS NE, et al.The genomic sequence of the Chinese hamster ovary(CHO)-K1 cell line[J]. Nature Biotechnology, 2011, 29(8): 735-741. [13] VILLACRES C, TAYI VS, BUTLER M.Strategic feeding of NS0 and CHO cell cultures to control glycan profiles and immunogenic epitopes of monoclonal antibodies[J]. Journal of Biotechnology, 2021, 333: 49-62. [14] GHADERI D, ZHANG M, ZIOLA NH, et al.Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of nonhuman sialylation[J]. Biotechnology & Genetic Engineering Reviews, 2012, 28: 147-75. [15] GAO YW, RAY S, DAI SJ, et al.Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess[J]. Biotechnology Journal, 2016, 11(9): 1190-1200. [16] WANG H, WANG C, WANG SJ, et al.Effect of sialic acid on human follicle stimulating hormone bioactivity assessment[J]. Chinese Jouranl of Pharmaceuticals(中国医药工业杂志), 2020, 51(6): 753-758. [17] VOLKHINA IV, BUTOLIN EG.Clinical and diagnostic significance of sialic acids determination in biological material[J]. Biochem Mosc Suppl B Biomed Chem, 2022, 16(3): 165-174. [18] WANG MH, LIN XX, JU MM, et al.Research progress in preparation and biological activity of sialic acid[J]. Journal of Pharmaceutical Research(药学研究), 2022, 41(9): 600-604. [19] SEO N, KO J, LEE D, et al.In-depth characterization of non-human sialic acid(Neu5Gc) in human serum using label-free ZIC-HILIC/MRM-MS[J]. Analytical and Bioanalytical Chemistry, 2021, 413: 5227-5237. [20] DU JJ, ZHANG QW, LI JJ, et al.LC-MS in combination with DMBA derivatization for sialic acid speciation and distribution analysis in fish tissues[J]. Anal Methods, 2020, 17: 2221-2227. [21] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume I I I(中华人民共和国药典三部)[M]. Beijing: China Medical Science Press, 2020: 628-684. |